-
Triple agonist (GLP-1/GIP/Glucagon) under investigation for weight management and metabolic optimization. Animal studies show enhanced fat oxidation and energy expenditure. -
Synthetic heptapeptide derived from tuftsin, studied for its nootropic and anxiolytic effects in central nervous system models. Linked to GABA modulation. -
GLP-1 receptor agonist studied for appetite regulation, glucose control, and weight management. Evaluated in multiple metabolic and diabetic models. -
Custom peptide formulation under experimental study for enhancement of sexual arousal pathways. Targets melanocortin and dopaminergic signaling systems. -
A growth hormone-releasing hormone analog used in research on pituitary stimulation and downstream GH/IGF-1 activity. -
Also known as Elamipretide, a mitochondrial-targeting peptide evaluated for restoring cardiolipin integrity, reducing ROS, and improving ATP output in mitochondrial dysfunction. -
Synthetic version of thymosin beta-4, evaluated for wound healing, inflammation modulation, and actin regulation across musculoskeletal tissues. -
GHRH analog studied for lipolytic activity, particularly targeting visceral fat. Originally developed for HIV-associated lipodystrophy. -
Download in seconds. Use for a lifetime. -
Peptide derived from thymus gland, researched for immunomodulatory roles in infection models, particularly viral and oncologic applications. -
Dual GIP and GLP-1 receptor agonist studied for glycemic control and weight loss. Demonstrates superior metabolic improvements in rodent and primate models.
Complimentary Upgrade to 2-Day Shipping on Orders Over $300 | Pay for standard — we’ll handle the upgrade.
You must be logged in to post a comment.